
Biogenes Technologies Sdn Bhd - Product Pipeline Analysis, 2024 Update
Description
Biogenes Technologies Sdn Bhd - Product Pipeline Analysis, 2024 Update
Summary
Biogenes Technologies Sdn Bhd (Biogenes Technologies) develops and commercializes molecular diagnostics and genome solutions. Its product includes DNA kits, aptamers (synthetic antibodies) and portable diagnostic kits, printed sensors, nano-coated sensor strips and other aptamers. The company develops, patents and commercializes technology platforms such as the aptamers design, aptamers sensing and aptamers synthesis platforms. Its products find application in the areas of human healthcare, animal breeding, agriculture and food safety. The company collaborates with research universities and institutions to develop its products. Biogenes Technologies is headquartered in Kajang, Selangor, Malaysia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Biogenes Technologies Sdn Bhd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
28 Pages
- Biogenes Technologies Sdn Bhd Company Overview
- Biogenes Technologies Sdn Bhd Company Snapshot
- Biogenes Technologies Sdn Bhd Pipeline Products and Ongoing Clinical Trials Overview
- Biogenes Technologies Sdn Bhd – Pipeline Analysis Overview
- Biogenes Technologies Sdn Bhd - Key Facts
- Biogenes Technologies Sdn Bhd - Major Products and Services
- Biogenes Technologies Sdn Bhd Pipeline Products by Development Stage
- Biogenes Technologies Sdn Bhd Pipeline Products Overview
- Aptamer-Based Diagnostic Kit - Diabetes
- Aptamer-Based Diagnostic Kit - Diabetes Product Overview
- Aptamer-Based Diagnostic Kit - Human Papillomavirus
- Aptamer-Based Diagnostic Kit - Human Papillomavirus Product Overview
- COVIDSENS
- COVIDSENS Product Overview
- SepsiDot
- SepsiDot Product Overview
- Ultralab - Colorectal Cancer Assay
- Ultralab - Colorectal Cancer Assay Product Overview
- Ultralab - Dengue Assay
- Ultralab - Dengue Assay Product Overview
- Ultralab - Influenza Assay
- Ultralab - Influenza Assay Product Overview
- Ultralab - MERS Assay
- Ultralab - MERS Assay Product Overview
- Ultralab - Streptococcus Infection Assay
- Ultralab - Streptococcus Infection Assay Product Overview
- Ultralab - Tuberculosis Assay
- Ultralab - Tuberculosis Assay Product Overview
- Biogenes Technologies Sdn Bhd - Key Competitors
- Biogenes Technologies Sdn Bhd - Key Employees
- Biogenes Technologies Sdn Bhd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Biogenes Technologies Sdn Bhd, Recent Developments
- Dec 19, 2022: Locally Made Sepsis Detection Test Kit to Hit the Market Soon
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Table 1: Biogenes Technologies Sdn Bhd Pipeline Products and Ongoing Clinical Trials Overview
- Table 2: Biogenes Technologies Sdn Bhd Pipeline Products by Equipment Type
- Table 3: Biogenes Technologies Sdn Bhd Pipeline Products by Indication
- Table 4: Biogenes Technologies Sdn Bhd, Key Facts
- Table 5: Biogenes Technologies Sdn Bhd, Major Products and Services
- Table 6: Biogenes Technologies Sdn Bhd Number of Pipeline Products by Development Stage
- Table 7: Biogenes Technologies Sdn Bhd Pipeline Products Summary by Development Stage
- Table 8: Aptamer-Based Diagnostic Kit - Diabetes - Product Status
- Table 9: Aptamer-Based Diagnostic Kit - Diabetes - Product Description
- Table 10: Aptamer-Based Diagnostic Kit - Human Papillomavirus - Product Status
- Table 11: Aptamer-Based Diagnostic Kit - Human Papillomavirus - Product Description
- Table 12: COVIDSENS - Product Status
- Table 13: COVIDSENS - Product Description
- Table 14: SepsiDot - Product Status
- Table 15: SepsiDot - Product Description
- Table 16: Ultralab - Colorectal Cancer Assay - Product Status
- Table 17: Ultralab - Colorectal Cancer Assay - Product Description
- Table 18: Ultralab - Dengue Assay - Product Status
- Table 19: Ultralab - Dengue Assay - Product Description
- Table 20: Ultralab - Influenza Assay - Product Status
- Table 21: Ultralab - Influenza Assay - Product Description
- Table 22: Ultralab - MERS Assay - Product Status
- Table 23: Ultralab - MERS Assay - Product Description
- Table 24: Ultralab - Streptococcus Infection Assay - Product Status
- Table 25: Ultralab - Streptococcus Infection Assay - Product Description
- Table 26: Ultralab - Tuberculosis Assay - Product Status
- Table 27: Ultralab - Tuberculosis Assay - Product Description
- Table 28: Biogenes Technologies Sdn Bhd, Key Employees
- Table 29: Biogenes Technologies Sdn Bhd, Subsidiaries
- Table 30: Glossary
- List of Figures
- Figure 1: Biogenes Technologies Sdn Bhd Pipeline Products by Equipment Type
- Figure 2: Biogenes Technologies Sdn Bhd Pipeline Products by Development Stage
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.